Pharmaceuticals company Wockhardt announced Q1FY27 results Consolidated Financial Highlights: Total Income: The company reported a Total Income of Rs 960 crore for Q1FY27, representing a growth of 26.65% YoY compared to Rs 758 crore in Q1FY26, though it saw a decline of 4.95% QoQ from Rs 1,010 crore in Q4FY26. Revenue from Operations: Revenue stood at Rs 929 crore in Q1FY27, showing a 25.88% YoY increase from Rs 738 crore in Q1FY26 and a 3.73% QoQ decrease from Rs 965 crore in Q4FY26. Profit Before Tax (PBT): For Q1FY27, PBT (before exceptional items) was Rs 116 crore, marking a significant turnaround from a loss of Rs 12 crore in Q1FY26. On a QoQ basis, it decreased by 30.54% from Rs 167 crore in Q4FY26. Net Profit: The company earned a Net Profit of Rs 107 crore in Q1FY27, compared to a net loss of Rs 108 crore in Q1FY26. It registered a 34.76% QoQ decline from Rs 164 crore in Q4FY26. Earnings Per Share (EPS): Basic and Diluted EPS for Q1FY27 was Rs 6.55, compared to a negative EPS of Rs 5.53 in Q1FY26 and Rs 10.23 in Q4FY26. Standalone Financial Highlights: Total Income: Standalone Total Income for Q1FY27 reached Rs 594 crore, reflecting a 35.62% YoY increase from Rs 438 crore in Q1FY26 and a 4.03% QoQ growth from Rs 571 crore in Q4FY26. Revenue from Operations: Standalone Revenue stood at Rs 561 crore in Q1FY27, a 35.84% YoY increase from Rs 413 crore in Q1FY26 and an 8.72% QoQ increase from Rs 516 crore in Q4FY26. Net Profit: Standalone Net Profit for Q1FY27 was Rs 107 crore, showing a 55.07% YoY growth from Rs 69 crore in Q1FY26 and a 35.93% QoQ decline from Rs 167 crore in Q4FY26. Earnings Per Share (EPS): Standalone Basic EPS for Q1FY27 was Rs 6.62, as against Rs 4.25 in Q1FY26 and Rs 10.29 in Q4FY26. Business Highlights: Group Structure: The consolidated results include the performance of Wockhardt Limited and its 28 subsidiaries as of June 30, 2026. Reporting Note: The figures for the quarter ended March 31, 2026 (Q4FY26), are the balancing figures between the audited figures of the full financial year and the reviewed published figures up to the third quarter of the financial year 2025-26. Board Update: The Board of Directors meeting for the approval of results commenced at 1:10 p.m. and concluded at 3:05 p.m. on August 10, 2026. Result PDF